概述
在过去十年里,用于药物发现的理性药物设计方法取得了长足的发展。它依赖于集成单元一样工作的交叉学科团队。近年来见证了药物发现研究的复杂性和药物发现团队使用的新技术的持续增长。因而,药化学家不得不广泛提高他们的知识库,当前则面临着陡峭的学习曲线。
药物设计电子学习
“分子理念学习系列”是一个创新的基于计算机的学习方案,它致力于将作为一个药物发现团队所必须的技能、技术和方法的药物化学、药物设计、化学信息学、结构信息学和分子建模等知识以摘要形式整合在一起。它提供了药化学家分析、理解和就药物的设计做出明智抉择从而使他们能有效推动药物发现进程所需要的全部信息。该学习系列由五个基于计算机的学习模块组成,每个模块专门为药物发现领域的学生和教授们提供面临哪怕最难的药物设计挑战所需要的综合训练。
药物发现模块
学习系列的每个模块从基本原理开始,向更多深入细节拓展,展示了丰富多彩的药物发现相关主题。使用交互式3D技术,实际例子和许多案例研究,用于药物发现的概念、方法和技术等都生动地呈现出来。
《Molecular Conceptor》目前被全球超过450个学术机构和制药公司所使用。
模块组成
Molecular Conceptor系列药物发现多媒体课程由5个学习模块组成。 每个模块根据药物设计领域所面临的挑战而精心设计,专为药物发现领域的学生与教师提供综合全面的培训课程。这些模块分别为:药物化学,药物设计,化学信息 学,结构生物学与药物发现案例分析。
Medicinal Chemistry药物化学课程模块涵盖的主题可以让您了解药物化学和药物化学家们日常所用的技术。本模块涵盖了诸如药物的分子基础、合理药物设计原理、结构-活性关系、定量构效关系、合成、生物电子等排原理、化合物库的设计以及ADME性质等之类的主题。 |
||
Drug Design现代药物发现领域总处于动态变化,这意味着新的技术正在不断发展以提高药物设计过程的产出。药物设计课程模块介绍了现代药物设计的方法学及其理论。本模块的主题包括了基于结构的药物设计、分子对接、基于配体的方法、药效团识别、类肽药物的开发和3D-QSAR。 |
||
Cheminformatics化学信息学课程模块讨论了在药物发现过程中计算化学家用到的计算技术。本章的主题包括:化学信息学的原理与应用、分子编码技术、三维数据库搜索、分子相似性和分子对接。 |
||
Structural Bioinformatics结构生物信息学课程模块讨论了用于预测和分析诸如蛋白之类生物大分子的三维结构分子模拟、结构分析、数据库搜索技术,以及这些信息相关的蛋白功能预测。还包括了将这些技术用在基于结构的药物设计上。 |
||
Practical Drug Discovery: Case Studies本课程为那些已经熟悉药物发现原理与技术的人而设计,”药物发现实践:案例研究”课程模块是由具体的例子和现实生活中的药物发现项目案例组成,讨论了各种药物设计技术药物设计如何应用于每一个案例中,以及这些方法的使用如何影响了项目的成败。 |
商业客户
学术客户
European Clients
- Biological Research Center – Hungary
- Comenius University – Slovakia
- Christian-Albrechts-University Kiel – Germany
- Dublin Institute of Technology – Ireland
- Dublin City University – Ireland
- Ecole Nationale Supérieure de Chimie (Mulhouse) – France
- Ecole Polytechnique Fédérale de Lausanne – Switzerland
- ETH – Switzerland
- Friedrich-Schiller-Universität Jena – Germany
- Gazi University – Turkey
- Hannover Medical School – Germany
- Heriott-Watt University – Scotland
- Hertfordshire University – United Kingdom
- IBCP – France
- ICM Warsaw University – Poland
- Institut fuer Molekulare Biotechnologie, Jena –Germany
- Institut de chimie pharmaceutique Albert Lespagnol (Lille 2) – France
- Institute of Cancer Therapeutics, University of Bradford – United Kingdom
- Joint Research Centre, European Commission – Italy
- Karl-Franzens-Universitaet Graz – Austria
- Kingston University London – United Kingdom
- Leiden Amsterdam Center for Drug Research (LACDR) – The Netherlands
- Lund University – Sweden
- Manchester Metropolitan University – United Kingdom
- Max-Plank Institute, Dortmund – Germany
- Medicinal Chemistry Institute – Spain
- Napier University – United Kingdom
- National Hellenic Research Foundation – Greece
- National Institute of Chemistry – Slovenia
- National Technical University of Athens – Greece
- Poznan University – Poland
- Queen’s University Belfast – Ireland
- Reims University – France
- Royal College of Surgeons Ireland – Ireland
- Royal Danish School of Pharmacy – Denmark
- Skopje University – Macedonia
- Slovak Academy of Sciences – Slovakia
- Technical University of Denmark – Denmark
- The University of Manchester – United Kingdom
- The University of Hertfordshire – United Kingdom
- The Leibniz-Institut fuer Molekulare Pharmakologie – Germany
- Trinity College Dublin – Ireland
- UAB – Spain
- UMIST – United Kingdom
- Universidad de la Laguna – Spain
- Universidad de Sevilla – Spain
- Universidad San Pablo CEU – Spain
- Universidade de Lisboa – Portugal
- Universitaet Bonn (Institut fuer Informatik) – Germany
- Universitaet Bonn (Poppelsdorf Pharmaceutical Institute) – Germany
- Universitaet Graz – Austria
- Universitat Pompeu Fabra – Spain
- Universität Tübingen – Germany
- Universiteit Antwerp – Belgium
- Université de Besançon – France
- Université de Bordeaux – France
- Université de Caen – France
- Université de Lille 2 – France
- Université d’Angers – France
- Université d’Orléans – France
- Université de Reims – France
- Université de Rennes 1 – France
- Université de Rouen – France
- Université des Sciences et Technologies de Lille – France
- Université Louis Pasteur – France
- University of Athens – Greece
- University A Coruna – Spain
- University of Barcelona – Spain
- University of Belgrade – Yugoslavia
- University of Burgos – Spain
- University of Coimbra – Portugal
- University College Dublin – Ireland
- University of Gent – Belgium
- University of Girona – Spain
- University of Grenoble – France
- University of Halle-Wittenberg – Germany
- University of Helsinki – Finland
- University of Kuopio – Finland
- University of Lausanne – Switzerland
- University of Leipzig – Germany
- University of Liege – Belgium
- University of Ljubljana – Slovenia
- University of Malaga – Spain
- University of Malta – Malta
- University of Montpellier I – France
- University of Münster – Germany
- University of Namur – Belgium
- University of Nijmegen – The Netherlands
- University of Paderborn – Germany
- University of Patras – Greece
- University of Porto – Portugal
- University of Regensburg – Germany
- University of Rovira i Virgili – Spain
- University of Saarland – Germany
- University of Salamanca – Spain
- University of Salerno – Italy
- University of Salford – United Kingdom
- University of Sarajevo – Bosnia
- University of Southern Denmark – Denmark
- University of Strathclyde – United Kingdom
- University of Valencia – Spain
- University of Wurzburg – Germany
- Uppsala University – Sweden
- Utrecht University – The Netherlands
- Vienna University of Technology – Austria
- Virtual Proteins BV – The Netherlands
- Vrije Universiteit Amsterdam – The Netherlands
- Vrije Universiteit Brussel – Belgium
- Warsaw University – Poland
- Yeditepe University – Turkey
Italian Consortium Members
- Università degli Studi di Milano – Italy
- Università degli Studi di Modena e Reggio Emilia – Italy
- Università degli Studi di Napoli Fredrico II – Italy
- Università degli Studi di Parma – Italy
- Università degli Studi di Roma ‘La Sapienza’ – Italy
- Università degli Studi di Salerno – Italy
- Università degli Studi di Sassari – Italy
- Università degli Studi di Siena – Italy
- Università di Bologna – Italy
- Università di Catania – Italy
- Università di Firenze – Italy
- Università di Messina – Italy
- Università di Pisa – Italy
- Università di Torino – Italy
- University of Bari – Italy
- University of Catanzaro – Italy
- University of Ferrara – Italy
- University of Genova – Italy
- University of Padova – Italy
- University of Palermo – Italy
- University of Pavia – Italy
- University of Perugia – Italy
North American Clients
- Arizona State University – USA
- Biotechnology Research Institute – Canada
- Boehringer Ingelheim – Canada
- Bronx Community College – USA
- California State University – USA
- Carleton University – Canada
- Colgate University – USA
- Genomics Institute of Novartis Research Foundation – USA
- Georgetown University – USA
- Georgia State University – USA
- Idaho State University – USA
- Lipscomb University – USA
- Lyon College – USA
- Michigan Technological University – USA
- National Research Council – Canada
- Neurogen Corporation – USA
- New Jersey Institute of Technology – USA
- New York University – USA
- NIH-NCI Frederick – USA
- Northeastern University – USA
- Palm Beach Atlantic University – USA
- Procter & Gamble Pharmaceuticals – USA
- Southern Methodist University – USA
- Spring Hill College – USA
- St. Jude Children’s Hospital – USA
- Structural Genomics Consortium – Canada
- The Johns Hopkins University – USA
- The University of British Columbia – Canada
- The University of Mississippi – USA
- The University of Tennessee – USA
- Transition Therapeutics, Inc. – Canada
- UCSD Center for Molecular Imaging – USA
- Union University – USA
- Université de Montréal – Canada
- University at Buffalo – USA
- University of Alabama – USA
- University of Houston – USA
- University of Iowa – USA
- University of Kansas – USA
- University of Louisville – USA
- University of Maryland Baltimore County – USA
- University of Massachusetts Lowell – USA
- University of New Mexico – USA
- University of Pennsylvania – USA
- University of Rhode Island – USA
- University of Richmond – USA
- University of Saskatchewan – Canada
- University of Texas at Austin – USA
- University of the Sciences in Philadelphia – USA
- University of Windsor – Canada
- Weill Cornell Medical College – USA
Worldwide Clients
- Ben-Gurion University – Israel
- BioCampus – India
- Bioinformatics Institute – Singapore
- Chonnam National University – South Korea
- Chungbuk National University – South Korea
- City University of Hong Kong – Hong Kong
- CSIRO Molecular and Health Technologies – Australia
- CSIRO Molecular Science – Australia
- Curtin University of Technology – Australia
- Ewha Womans University – South Korea
- Information & Communications University – South Korea
- Institute Technology of Bandung – Indonesia
- KIST – South Korea
- Krasnoyarsk State Medical Academy – Russian Federation
- Kumamoto University – Japan
- Kyung Hee University – South Korea
- Nanyang Technological University – Singapore
- National Chung Cheng University – Taiwan
- National Defense Medical Center – Taiwan
- National Tsing Hua University – Taiwan
- Nippon Shinyaku – Japan
- NUS – Singapore
- Polytechnic University of Hong Kong – Hong Kong
- Pontifcia Universidade Catolica do Rio Grande do Sul – Brasil
- Rhodes University – South Africa
- Seoul National University – South Korea
- Sookmyung Women’s University – South Korea
- Taipei Medical University – Taiwan
- Tel Aviv University – Israel
- The Hebrew University of Jerusalem – Israel
- The Hong Kong University of Science & Technology – Hong Kong
- The Tajen Institute of Technology – Taiwan
- The University of Adelaide – Australia
- The University of Tokushima – Japan
- Tokyo University of Science – Japan
- UFRJ – Brasil
- UFPE – Brazil
- UNAM – Mexico
- Univali – Brazil
- University of Abobo-Adjame – Ivory Coast
- University of Cape Town – South Africa
- University of Chile – Chile
- University of Hong Kong – Hong Kong
- University of Guanuajato – Mexico
- University of Karachi – Pakistan
- University of Sao Paulo – Brasil
- University of Sydney – Australia
- University of Tasmania – Australia
- VEL GROUP – CHENNAI – India
- Yonsei University – South Korea
Synergix公司简介
Synergix有限公司成立于1996,其创办人为N.C Cohen博士,他是一个理性药物设计的先驱。公司致力于为药物设计、分子建模、化学信息学和药物化学开发教育资源。
2002,公司推出了交互式、多媒体网络课程:“分子理念(Molecular Conceptor)”。该课程展示了药物设计领域背后所隐藏的多学科多领域的知识和基础。2009,对程序进行了改版并使之成为一个模块化的学习资源:分子理念学习系列。
我们的开发团队包括专业的科学家和软件开发人员,是他们指导着产品方向和并保证其内容持续地高质量。
我们希望通过使用分子理念学习系列,我们可以为帮助药物发现做出间接的贡献。
Synergix公司创始人简介
N. Claude Cohen – Chairman & CEO
当Cohen博士从法国巴黎大学获得有机化学博士后,他立即加入巴黎的罗素优克福(Roussel-Uclaf, 现在的赛诺菲-安万特, Sanofi-Aventis)。在巴黎,他担任理论药物化学部的负责人,带领他的团队开展了非常多的心血管药物发现项目。
Cohen博士开发了一大批三维药物设计方法,并用于中枢神经系统、CVS、感染、免疫与肿瘤等治疗领域的药物发现项目。
后来,他参入了瑞士汽巴-嘉基(Ciba-Geigy, 现在的诺华,Novartis)担任分子建模和药物设计的负责人。他的团队成功地将现代理性药物设计理念整合到公司的研究项目,跟他的同事一起Cohen博士发现了几种药物,其中包括缬沙坦(Valsartan, 代文, Diovan)和阿利吉仑(Tekturna / Rasilez)。2008年缬沙坦的总收入为50亿美元,阿利吉仑(Tekturna / Rasilez)是一种肾素抑制剂,于2007实现商业化。鉴于他对当今药物发现方法和技术所做出的贡献,Cohen博士被同行认为合理药物设计的先驱者。
在2009年七月,由于他们发现并开发了一类新药肾素抑制剂阿利吉仑,Cohen和他的Novatis团队成员一起被评为ACS化学英雄(ACS Hero of Chemistry)。